| Dr Katherine Kar-hwee Quan, MD | |
|
1100 S Dobson Rd Ste 223, Chandler, AZ 85286-6160 | |
| (480) 821-8888 | |
| (480) 821-0888 |
| Full Name | Dr Katherine Kar-hwee Quan |
|---|---|
| Gender | Female |
| Speciality | Micrographic Dermatologic Surgery (mds) |
| Experience | 32 Years |
| Location | 1100 S Dobson Rd Ste 223, Chandler, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629051917 | NPI | - | NPPES |
| 385551 | Medicaid | AZ | |
| 070011301 | Other | AZ | RAILROAD MEDICARE |
| 86080015085259A375 | Other | AZ | TRIWEST |
| 41-2054293 | Other | AZ | TAX-ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | 25345 (Arizona) | Primary |
| 207N00000X | Dermatology | 25345 (Arizona) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| East Valley Dermatology Center | 8022093384 | 15 |
News Archive
Pyrexar Medical begins operations today after completing the acquisition of hyperthermia assets held by Perseon, formerly BSD Medical. This acquisition includes substantially all hyperthermia assets, products, services and related intellectual property.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
University of Minnesota Medical School researchers from the Masonic Cancer Center, University of Minnesota, in partnership with the University's Brain Tumor Program, have developed a new mouse model of malignant peripheral nerve sheath tumors that allow them to discover new genes and gene pathways driving this type of cancer.
Behavioral experiment on reward and punishment highlights the cumulative effect of punishment in children with ADHD.
› Verified 7 days ago
| Entity Name | East Valley Dermatology Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366529836 PECOS PAC ID: 8022093384 Enrollment ID: O20040621001518 |
News Archive
Pyrexar Medical begins operations today after completing the acquisition of hyperthermia assets held by Perseon, formerly BSD Medical. This acquisition includes substantially all hyperthermia assets, products, services and related intellectual property.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
University of Minnesota Medical School researchers from the Masonic Cancer Center, University of Minnesota, in partnership with the University's Brain Tumor Program, have developed a new mouse model of malignant peripheral nerve sheath tumors that allow them to discover new genes and gene pathways driving this type of cancer.
Behavioral experiment on reward and punishment highlights the cumulative effect of punishment in children with ADHD.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Katherine Kar-hwee Quan, MD 1100 S Dobson Rd Ste 223, Chandler, AZ 85286-6160 Ph: (480) 821-8888 | Dr Katherine Kar-hwee Quan, MD 1100 S Dobson Rd Ste 223, Chandler, AZ 85286-6160 Ph: (480) 821-8888 |
News Archive
Pyrexar Medical begins operations today after completing the acquisition of hyperthermia assets held by Perseon, formerly BSD Medical. This acquisition includes substantially all hyperthermia assets, products, services and related intellectual property.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
University of Minnesota Medical School researchers from the Masonic Cancer Center, University of Minnesota, in partnership with the University's Brain Tumor Program, have developed a new mouse model of malignant peripheral nerve sheath tumors that allow them to discover new genes and gene pathways driving this type of cancer.
Behavioral experiment on reward and punishment highlights the cumulative effect of punishment in children with ADHD.
› Verified 7 days ago
Joseph David Allgeier, DO Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3930 S Alma School Rd Ste 8, Chandler, AZ 85248 Phone: 480-917-4815 Fax: 480-963-2654 | |
Jill J Mckenzie, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1100 S Dobson Rd, 223, Chandler, AZ 85286 Phone: 480-821-8888 Fax: 480-821-0888 | |
Burrell Harvey Wolk, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 725 S Dobson Rd, Suite 200, Chandler, AZ 85224 Phone: 480-899-7546 Fax: 480-899-7599 | |
Dr. Ryan Lee Owen, D.O, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 725 S Dobson Rd Ste 200, Chandler, AZ 85224 Phone: 480-899-7546 | |
Dr. Edward Prodanovic, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 725 S Dobson Rd, Chandler, AZ 85224 Phone: 480-899-7546 Fax: 480-899-7599 | |
Dr. Ryan Falsey, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1100 S Dobson Rd, #223, Chandler, AZ 85286 Phone: 480-821-8888 Fax: 480-821-0888 | |
Susan Rutledge Pardee, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 312 N Alma School Rd Ste 5, Chandler, AZ 85224 Phone: 480-948-8400 Fax: 480-948-8401 |